Topical 5% 5-Fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: a retrospective cohort analysis, Supplemental Materials

Published: 20 August 2021| Version 1 | DOI: 10.17632/7c342wkw7g.1
holly neale


Study methods and descriptive characteristics of SCCIS and sBCC patients and tumors that were treated with topical 5-fluorouracil 5% cream (5-FU) and all other modalities (electrodessication and curettage, laser and curettage, cryotherapy +/- curettage, Mohs surgery, shave removal, or surgical excision). Data was gathered through a retrospective chart review of patients seen at the University of Massachusetts Department of Dermatology from 2008-2012.